232 related articles for article (PubMed ID: 22554312)
41. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
[TBL] [Abstract][Full Text] [Related]
42. Leveraging Quantitative Systems Pharmacology Approach into Development of Human Recombinant Follistatin Fusion Protein for Duchenne Muscular Dystrophy.
Nguyen HQ; Iskenderian A; Ehmann D; Jasper P; Zhang Z; Rong H; Welty D; Narayanan R
CPT Pharmacometrics Syst Pharmacol; 2020 Jun; 9(6):342-352. PubMed ID: 32419339
[TBL] [Abstract][Full Text] [Related]
43. Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition.
MacDonald EM; Andres-Mateos E; Mejias R; Simmers JL; Mi R; Park JS; Ying S; Hoke A; Lee SJ; Cohn RD
Dis Model Mech; 2014 Apr; 7(4):471-81. PubMed ID: 24504412
[TBL] [Abstract][Full Text] [Related]
44. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
Fallon JR; McNally EM
Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
[TBL] [Abstract][Full Text] [Related]
45. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
46. The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle.
Rybalka E; Timpani CA; Debruin DA; Bagaric RM; Campelj DG; Hayes A
Cells; 2020 Dec; 9(12):. PubMed ID: 33322031
[TBL] [Abstract][Full Text] [Related]
47. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
[TBL] [Abstract][Full Text] [Related]
48. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
49. Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone.
Iskenderian A; Liu N; Deng Q; Huang Y; Shen C; Palmieri K; Crooker R; Lundberg D; Kastrapeli N; Pescatore B; Romashko A; Dumas J; Comeau R; Norton A; Pan J; Rong H; Derakhchan K; Ehmann DE
Skelet Muscle; 2018 Oct; 8(1):34. PubMed ID: 30368252
[TBL] [Abstract][Full Text] [Related]
50. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle.
Hammers DW; Hart CC; Patsalos A; Matheny MK; Wright LA; Nagy L; Sweeney HL
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31830002
[TBL] [Abstract][Full Text] [Related]
52. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
53. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
[TBL] [Abstract][Full Text] [Related]
54. The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
Muntoni F; Byrne BJ; McMillan HJ; Ryan MM; Wong BL; Dukart J; Bansal A; Cosson V; Dreghici R; Guridi M; Rabbia M; Staunton H; Tirucherai GS; Yen K; Yuan X; Wagner KR;
Neurol Ther; 2024 Feb; 13(1):183-219. PubMed ID: 38190001
[TBL] [Abstract][Full Text] [Related]
55. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
56. Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice Modulation.
Lu-Nguyen N; Dickson G; Malerba A
Methods Mol Biol; 2018; 1828():343-354. PubMed ID: 30171552
[TBL] [Abstract][Full Text] [Related]
57. Post-exercise changes in myostatin and actRIIB expression in obese insulin-resistant rats.
Bueno PG; Bassi D; Contrera DG; Carnielli HM; Silva RN; Nonaka KO; Selistre-de-Araújo HS; Leal AM
Mol Cell Endocrinol; 2011 Jun; 339(1-2):159-64. PubMed ID: 21539891
[TBL] [Abstract][Full Text] [Related]
58. Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.
Takayama K; Noguchi Y; Aoki S; Takayama S; Yoshida M; Asari T; Yakushiji F; Nishimatsu S; Ohsawa Y; Itoh F; Negishi Y; Sunada Y; Hayashi Y
J Med Chem; 2015 Feb; 58(3):1544-9. PubMed ID: 25569186
[TBL] [Abstract][Full Text] [Related]
59. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial.
Campbell C; McMillan HJ; Mah JK; Tarnopolsky M; Selby K; McClure T; Wilson DM; Sherman ML; Escolar D; Attie KM
Muscle Nerve; 2017 Apr; 55(4):458-464. PubMed ID: 27462804
[TBL] [Abstract][Full Text] [Related]
60. Erythropoietin reduces the expression of myostatin in mdx dystrophic mice.
Feder D; Rugollini M; Santomauro A; Oliveira LP; Lioi VP; Santos Rd; Ferreira LG; Nunes MT; Carvalho MH; Delgado PO; Carvalho AA; Fonseca FL
Braz J Med Biol Res; 2014 Nov; 47(11):966-71. PubMed ID: 25296358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
